Loading...

Industry News

SynBioBeta brings you the latest news in synthetic biology. Have news to share? Contact us to submit your story.

Subscribe

Stay updated on the latest news in synthetic biology

Subscribe to the SynBioBeta news digest
Subscribe

Featured Articles

Latest News

October 2018

AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering

Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies

ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion And Platform Development For Cell Therapy

Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards

Mars Taps Benson Hill’s Crop Design Platform to Help Protect Cacao from Climate Change

Organic farming with gene editing: An oxymoron or a tool for sustainable agriculture?

BioBricks Foundation Announces Publication of OpenMTA in Nature Biotechnology

PerkinElmer Launches Asset Genius™ System for Remote Laboratory Monitoring

Global Bioenergies reaches 87% of yield target in Isobutene process

A clash of titans: DIY Bio met the homebrew computer club at SynBioBeta 2018

Meet Staph epidermidis, gatekeeper of healthy skin

A Pulitzer Prize for Evolutionary Biology

TWB contributes to the development of synthetic biology in France

Twist Bioscience Files for $86.3M IPO

Genomatica Completes $90 Million Financing to Drive Technologies for More Sustainable Everyday Products

Riffyn launches Open Access for scientists at non-profits

tadalafiltablets findviagra.com http://xanaxonlinebuy.com/